And what makes a new candidate drug called COYA 302, an investigational therapy for ALS, different? COYA 302 is a dual-mechanism investigational biologic combination therapy. To explore this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback